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Introduction
Various allergens, airborne irritants, and infec­
tions trigger exacerbation of asthma. Because 
people spend > 75% of their time indoors 
(Klepeis et al. 2001), exposures found in the 
indoor environment are paramount. In 2000, 
the Committee on the Assessment of Asthma 
and Indoor Air of the Institute of Medicine 
(IOM) reviewed and summarized the scientific 
evidence for relationships between indoor air 
exposures and the exacerbation and develop­
ment of asthma (IOM 2000). For exacer  ba­
tion of asthma, sufficient evidence showed 
a causal relationship for four exposures and 
association for five exposures, and limited or 
suggestive evidence showed association with 
nine exposures. Since 2000, a substantial 
amount of research on indoor environmental 
exposures and exacerbation of asthma has been 
conducted. In this review we aim to provide a 
comprehensive update on this topic. 
Methods
We examined publications since 2000 relating 
indoor exposures and exacerbation of asthma 
in conjunction with prior evidence (IOM 
2000) and provide conclusions about the 
current strength of evidence. We used a set of 
previously defined categories for strength of 
evidence (IOM 2000): a) sufficient evidence 
of causal relationship, b) sufficient evidence 
of an association, c) limited or suggestive 
evidence of an association, d) inadequate or 
insufficient evidence to determine whether 
or not an association exists, and e) limited 
or suggestive evidence of no association (for 
category descriptions, see Supplemental 
Material, Table S1).
Specific Priorities, Inclusions, and 
Exclusions
In this review we considered the evidence 
that specific indoor environmental exposures 
might cause exacerbation of asthma. Eligible 
outcome measures, all among asthmatics, 
included frequency or severity of respiratory 
symptoms, illness­related school absences, 
urgent care or emergency department visits, 
hospitalization, unscheduled health care visits, 
amount or frequency of medicine for asthma 
control or prevention, airway inflammation 
assessed by fraction of exhaled nitric oxide 
(FeNO), and asthma­related quality of life.
Potentially modifiable biological and 
chemical exposures resulting from indoor 
sources were considered for inclusion as poten­
tial causes of asthma morbidity. Infectious 
agents and outdoor­generated pollutants that 
penetrate buildings were excluded. Studies 
on new onset of asthma, asthma prevalence, 
or experimental biologic markers of asthma 
were excluded.
Only studies of human health effects 
were included. Eligible study designs were 
controlled (experimental) exposure studies, 
environmental intervention studies, and 
a variety of observational designs: prospec­
tive or retrospective (longitudinal) cohort, 
case–control, and cross­sectional. Case studies 
and case series were ineligible. Detailed 
inclusion and exclusion criteria are described 
in the Supplemental Material, “Study 
 inclusion  criteria.”
Literature Search
PubMed searches were performed in May and 
August 2011 and updated in August 2013. 
Search terms focused primarily on the indoor 
environmental risk factors considered in the 
IOM 2000 review. We added the category 
tag “major” to identify articles that included 
the IOM risk factor as a main topic and 
the broader category tag “mesh” to identify 
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Background: Previous research has found relationships between specific indoor environmental 
exposures and exacerbation of asthma.
oBjectives: In this review we provide an updated summary of knowledge from the scientific literature 
on indoor exposures and exacerbation of asthma.
Methods: Peer-reviewed articles published from 2000 to 2013 on indoor exposures and 
exacerbation of asthma were identified through PubMed, from reference lists, and from authors’ files. 
Articles that focused on modifiable indoor exposures in relation to frequency or severity of exacerba-
tion of asthma were selected for review. Research findings were reviewed and summarized with 
consideration of the strength of the evidence.
results: Sixty-nine eligible articles were included. Major changed conclusions include a causal 
relationship with exacerbation for indoor dampness or dampness-related agents (in children); 
associations with exacerbation for dampness or dampness-related agents (in adults), endotoxin, 
and environmental tobacco smoke (in preschool children); and limited or suggestive evidence for 
associa  tion with exacerbation for indoor culturable Penicillium or total fungi, nitrogen dioxide, 
rodents (nonoccupational), feather/down pillows (protective relative to synthetic bedding), and 
(regardless of specific sensitization) dust mite, cockroach, dog, and dampness-related agents.
discussion: This review, incorporating evidence reported since 2000, increases the strength of 
evidence linking many indoor factors to the exacerbation of asthma. Conclusions should be considered 
provisional until all available evidence is examined more thoroughly.
conclusion: Multiple indoor exposures, especially dampness-related agents, merit increased 
attention to prevent exacerbation of asthma, possibly even in nonsensitized individuals. 
Additional research to establish causality and evaluate interventions is needed for these and other 
indoor exposures.
citation: Kanchongkittiphon W, Mendell MJ, Gaffin JM, Wang G, Phipatanakul W. 2015. 
Indoor environmental exposures and exacerbation of asthma: an update to the 2000 review by the 
Institute of Medicine. Environ Health Perspect 123:6–20;  http://dx.doi.org/10.1289/ehp.1307922Indoor exposures and exacerbation of asthma
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articles that included the IOM risk factors 
as a subject, but not necessarily as a main 
topic. This search strategy was designed to 
exclude editorials, letters, commentaries, 
clinical trials (phases 1–4) that would assess 
drug development and efficacy, and studies 
focusing on genetic predisposition or poly­
morphisms associated with asthma develop­
ment. In addition, this search was restricted 
to findings published in English during the 
past 13 years. For further details regarding the 
search strategy, see Supplemental Material, 
“Literature search strategy.”
In total, the searches yielded 2,570 
articles. After application of inclusion and 
exclusion criteria to the abstracts, we identi­
fied 162 articles of preliminary interest. We 
further excluded 99 studies after reviewing 
the full articles. Six additional peer­reviewed 
articles from reference lists or researchers’ 
files were included. Finally, 69 articles were 
selected for this review article. We considered 
recent findings in conjunction with evidence 
cited in the IOM (2000).
Results
We organized evidence and conclusions by 
specific risk factors or exposures, ordered in 
categories by the previous strength of evidence 
for causation or association with exacer  ba­
tion of asthma, as presented in the 2000 IOM 
review. Each section addresses a specific risk 
factor or exposure, presenting background 
material on the agent with conclusions from 
the IOM (2000) report, a summary of new 
evidence with considera  tion of prior evidence, 
and updated conclusions. Results are summa­
rized in Table 1. A reevalua  tion of prior 
evidence cited in the IOM (2000) review is 
provided in Supplemental Material, “Prior 
evidence for selected exposures (IOM 2000).” 
Eligible studies included in the current 
review are listed in Supplemental Material, 
Tables S2–S13.
Exposures for which Sufficient 
Evidence Had Existed for Causation 
of Exacerbation of Asthma
House dust mite allergens. Background. 
Der p 1 and Der p 2, the major allergens identi­
fied from house dust mites (Dermatophagoides 
pteronyssinus), are concentrated in particles of 
mite feces. Because the allergens are found on 
large particles (mostly ≥ 10 μm), they become 
airborne relatively briefly when disturbed. 
Studies have found that exposure to dust mite 
allergens is associated with dust mite sensi­
tization, which is associated with asthma. 
Reduction of exposure to these allergens 
decreases asthma symptoms in mite­sensitive 
asthmatics (IOM 2000). Mechanistic studies 
have implicated both allergic and nonallergic 
mechanisms in inducing airway inflammation, 
mirroring some clinical findings of dust 
mite–induced asthma morbidity in 
non  sensitized subjects. Protease activity of 
dust mite allergen can act on airway epithelial 
cells to induce disruption of the tight junc­
tions between epithelial cells and activation 
of protease­activated receptor­2 (PAR­2), 
facilitating allergen delivery across epithelium 
(Jeong et al. 2008). Activation of PAR­2 can 
trigger an innate immune response and the 
release of pro  inflammatory cytokines, such 
as interleukin­6 (IL­6) and IL­8 from airway 
epithelial cells (Kauffman 2006; Matsumura 
2012). Citing the many studies that had 
found exposure to dust mite allergens to be 
associated with dust mite sensitization—which 
was in turn associated with asthma—and 
reduction of exposure to dust mite aller­
gens to be associated with decreased asthma 
symptoms in mite­sensitive asthmatics, the 
IOM concluded:
• There is sufficient evidence of a causal rela­
tionship between dust mite allergen exposure 
and exacerbations of asthma in indi­
viduals specifically sensitized to dust mites. 
Continual exposure to dust mite allergens 
is also a contributing cause of chronic bron­
chial hyperreactivity (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S2 summa­
rizes recent reported findings from 11 studies 
on associations of dust mite allergens with 
exacer  ba  tion of asthma: in children, one 
randomized controlled trial, four prospec­
tive studies, and four cross­sectional studies 
(including one with case–control selection 
but cross­sectional analysis); in adults, one 
randomized control trial; and in children and 
adults, one cross­sectional study with findings 
reported only for adults.
In specifically sensitized children, 
the intervention trial (El­Ghitany and 
Abd El­Salam 2012) and all four prospec­
tive studies (Gent et al. 2009, 2012; Halken 
et al. 2003; Nitschke et al. 2006) found asso­
ciations of dust mite exposure with exacer­
ba  tion, with Gent et al. (2009) reporting a 
dose­related association of dust mite antigen 
with wheeze. Of three cross­sectional assess­
ments, one (Spanier et al. 2006) found 
significant positive associations of dust mite 
exposure with exacer  ba  tion, one (Murray 
et al. 2006) found a nonsignificant increase, 
and one (Rabito et al. 2011) found no 
association. In children not specifically sensi­
tized, the only prospective study (Gent et al. 
2009) and one (Spanier et al. 2006) of two 
(Rabito et al. 2011) cross­sectional studies 
found associations. In children of unknown 
sensitization, the one study (Turyk et al. 
2006) found no association. In adults, the 
one study in specifically sensitized adults 
found no greater benefits associated with a 
dust mite reduction inter  vention than with 
control conditions (Dharmage et al. 2006). 
In adults who were not specifically sensitized 
but were atopic asthmatics, a cross­sectional 
study found that exposure to dust mite 
allergen was significantly associated with more 
severe bronchial hyperresponsiveness (Langley 
et al. 2005). Spanier et al. (2006) reported a 
positive association between dust mite allergen 
level and FeNO in dust mite–sensitized 
children, suggesting a direct role in airway 
inflammation.
Evidence from the IOM (2000), while 
clearly documenting that dust mite allergen 
exposure caused asthma in dust mite–sensitive 
children, was less clear in documenting that 
such exposure caused exacer  ba  tion of existing 
asthma. The strongest evidence for this—the 
available intervention studies—also involved 
many changes other than dust mite reduc­
tion. In the evidence currently available, dust 
mite exposure consistently is positively associ­
ated with various measures of exacer  ba  tion or 
severity of asthma in children, including in 
studies of strong design, with proper tempo­
rality, and with biologic plausibility demon­
strated. In children not specifically sensitized 
the evidence is more sparse, although more 
positive than negative. In adults the sparse 
evidence is not consistent, but only suggestive.
Conclusions.
• There is sufficient evidence of a causal rela­
tionship between exposure to dust mite 
allergen and exacer  ba  tion of asthma in 
children sensitized to dust mites.
• There is limited or suggestive evidence of 
an association between dust mite allergen 
exposure and exacer  ba  tions of asthma in 
children not sensitized to dust mites and in 
adults, whether sensitized or nonsensitized.
Cat allergen. Background. Fel d 1 has 
been identified as the major cat allergen. 
High levels of Fel d 1 are found in the air 
and dust of homes with cats, but are also 
found in many buildings without resident 
cats (IOM 2000). The mix of prior findings 
in studies of cat allergens, atopy, and asthma 
was complex, possibly suggesting different 
effects depending on age at exposure, level 
of exposure, and sensitization status. Early 
exposure to cats appeared possibly to prevent 
sensitization to cat allergens in some children, 
although findings were inconsistent. The 
IOM concluded: 
• There is sufficient evidence of a causal 
relationship between cat allergen exposure 
and exacer  ba  tion of asthma in individuals 
specifically sensitized to cats (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S3 summarizes 
evidence from seven recent available studies: 
in children, three prospective and three cross­
sectional, and in adults and children, one 
cross­sectional.
The prospective study by McConnell 
et al. (2006) found that associations of Kanchongkittiphon et al.
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various air pollutants with bronchitic 
symptoms were generally greater among 
children living in a home with a cat. Several 
studies have also demonstrated that among 
cat­sensitized children, cat allergen exposure 
had a positive association with increased 
asthma severity, rescue medication use, 
frequency of asthma symptoms, or FeNO: 
two prospective studies (Gent et al. 2009, 
2012) and one cross­sectional (Murray et al. 
2006). In other cross­sectional studies, Turyk 
et al. (2006) found no significant associations, 
and Spanier et al. (2006) found that high 
levels of cat allergen exposure and owning a 
cat were both associated with lower FeNO 
(i.e., less airway inflammation). This last 
finding may be biased by cat­allergic subjects 
tending not to own cats. In asthmatic adults 
who were atopic but not sensitized to cat, 
no association was observed between Fel d 1 
and asthma, including measures of forced 
expiratory volume in 1 sec (FEV1), provoca­
tion dose causing fall in FEV1 of at least 20% 
(PD20), and FeNO (Langley et al. 2005).
Thus, findings in children from prospec­
tive studies are fully consistent, and those 
from cross­sectional studies partly consistent, 
Table 1. Prior and updated conclusions about strength of evidence linking specific indoor exposures to increased exacerbation of asthma in asthmatic 
individuals.
Exposures according to prior strength 
of evidence, per IOM (2000) Prior conclusions (IOM 2000) Updated conclusions
Sufficient evidence for causation
House dust mite allergens There is sufficient evidence of a causal relationship between 
dust mite allergen exposure and exacerbations of asthma in 
individuals specifically sensitized to dust mites. Continual 
exposure to dust mite allergens is also a contributing cause 
of chronic bronchial hyperreactivity.
There is sufficient evidence of a causal relationship between exposure 
to dust mite allergen and exacerbation of asthma in children sensitized 
to dust mites.
There is limited or suggestive evidence of an association between 
dust mite allergen exposure and exacerbations of asthma in children 
not sensitized to dust mites and in adults, specifically sensitized or 
nonsensitized.
Cat allergens There is sufficient evidence of a causal relationship between 
cat allergen exposure and exacerbation of asthma in 
individuals specifically sensitized to cats.
There is sufficient evidence of a causal relationship between cat 
allergen exposure and exacerbation of asthma in individuals 
specifically sensitized to cats.
Cockroach allergens There is sufficient evidence of a causal relationship between 
cockroach allergen exposure and exacerbation of asthma in 
individuals specifically sensitized to cockroaches.
There is sufficient evidence of a causal relationship between cockroach 
allergen exposure and exacerbations of asthma in individuals 
specifically sensitized to cockroaches, especially adults.
There is limited or suggestive evidence of association between 
cockroach allergen exposure and exacerbation of asthma in children 
not sensitized to cockroaches.
ETS There is sufficient evidence to conclude that there is a causal 
relationship between chronic ETS exposure and exacerbations 
of asthma in preschool-age children.
There is limited or suggestive evidence of a relationship 
between chronic ETS exposure and exacerbations of asthma 
in older children and adults.
There is limited or suggestive evidence of an association 
between acute ETS exposure and exacerbation in asthmatics 
sensitive to this exposure.
There is sufficient evidence of an association between chronic ETS 
exposure and exacerbations of asthma in preschool-age children.
There is limited or suggestive evidence of an association between 
chronic ETS exposure and exacerbations of asthma in older children 
and adults.
There is limited or suggestive evidence of an association between acute 
ETS exposure and exacerbation of asthma in asthmatics sensitive to 
this exposure.
Sufficient evidence for association
Dog allergens  There is sufficient evidence of an association between dog 
allergen exposure and exacerbation of asthma in individuals 
specifically sensitized to dogs.
There is sufficient evidence of an association between dog allergen 
exposure and exacerbations of asthma in children sensitized to dogs.
There is limited or suggestive evidence of an association between 
dog allergen exposure and exacerbations of asthma in nonsensitized 
adults.
Fungi (quantified) There is sufficient evidence of an association between fungal 
exposure and symptom exacerbation in sensitized asthmatics. 
Exposure may also be related to nonspecific chest symptoms.
There is sufficient evidence of a causal association between outdoor 
culturable fungal exposure and exacerbation in asthmatics sensitized 
to fungi. 
There is limited or suggestive evidence of an association between 
indoor culturable Penicillium exposure and exacerbation in asthmatic 
children with specific sensitization, any fungal sensitization, or 
unspecified sensitization.
There is limited or suggestive evidence of an association between 
indoor total culturable fungal exposure and exacerbation of asthma in 
children with any fungal sensitization.
Dampness or dampness-related 
agents
Dampness may exacerbate existing asthma. The factors related 
to dampness that actually lead to the development of disease 
and to disease exacerbation are not yet confirmed, but probably 
relate to dust mite and fungal allergens.
There is sufficient evidence of a causal association between dampness 
or dampness-related agents and exacerbation of asthma in children, 
and of an association in adults. The evidence does not suggest that this 
relationship is restricted to those with specific sensitization to fungi or 
dust mites.
Nitrogen dioxide (NO2)  There is sufficient evidence of an association between brief 
high-level exposures to NO2 and increased airway responses 
to both nonspecific chemical irritants and inhaled allergens 
among asthmatic subjects. These effects have been observed 
in human chamber studies at concentrations that may occur 
only in poorly ventilated kitchens with gas appliances in use.
There is sufficient evidence of an association between brief high-level 
exposures to NO2 and increased airway responses to nonspecific 
chemical irritants and inhaled allergens among asthmatic subjects.
There is limited or suggestive evidence of an association between 
NO2 and exacerbation of asthma, although this association may be 
attributable to confounding by other consistently correlated emissions 
from gas stoves.
There is inadequate or insufficient evidence to determine whether an 
association exists between gas stove use and exacerbation of asthma.
ContinuedIndoor exposures and exacerbation of asthma
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with prior findings that cat allergen exposure 
among cat­sensitized individuals (presum­
ably with inflamed airways) increases 
asthma symptoms.
Conclusion.
• There is sufficient evidence of a causal 
relationship between cat allergen exposure 
and exacer  ba  tion of asthma in individuals 
  sensitized to cats.
Cockroach allergens. Background. The 
major cockroach allergens include enzymes 
in fecal pellets that are incorporated into 
household dust (Rabito et al. 2011). 
Cockroach allergen exposure is common in 
inner­city residences and was considered to 
be an important influence on the high rates 
of asthma among inner­city children (IOM 
2000). The evidence cited by the IOM 
(2000) was limited but consistent, with two 
positive controlled exposure studies showing 
responses in specifically sensitized adults and 
one positive prospective observational study in 
children. There was documented association, 
biologic plausibility, and apparent causality 
in specifically sensitized individuals. The 
IOM concluded:
• There is sufficient evidence of a causal 
relationship between cockroach allergen 
exposure and exacer  ba  tion of asthma in 
individuals specifically sensitized to cock­
roaches (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S4 summa­
rizes findings from seven recent studies: one 
prospective and six cross­sectional, all in 
children; one study also included adults.
Table 1. Continued.
Exposures according to prior strength 
of evidence, per IOM (2000) Prior conclusions (IOM 2000) Updated conclusions
Limited or suggestive evidence for association
Domestic birds There is limited or suggestive evidence of an association between 
bird exposure and exacerbation of symptoms in bird-sensitized 
asthmatics. This association may be confounded by the allergic 
asthmatic response to mites harbored by birds.
There is limited or suggestive evidence of an association between 
exposure to birds and the exacerbation of symptoms in bird-sensitized 
asthmatics. This association may be confounded by the allergic 
asthmatic response to mites harbored by birds.
Formaldehyde (nonoccupational)  There is limited or suggestive evidence of an association 
between formaldehyde exposure and wheezing and other 
respiratory symptoms.
There is limited or suggestive evidence of an association between 
formaldehyde exposure and exacerbations of asthma, particularly 
through enhanced response to other allergens.
Fragrances, some  There is limited or suggestive evidence of an association 
between exposure to certain fragrances and the manifestation 
of respiratory symptoms in asthmatics sensitive to such 
exposures. 
There is limited or suggestive evidence of an association between 
exposure to certain fragrances and the manifestation of respiratory 
symptoms in asthmatics sensitive to such exposures.
Inadequate or insufficient evidence for association
Rodents (acute, nonoccupational) There is sufficient evidence of an association between exposure 
to rodents in a laboratory setting and exacerbation of 
symptoms or lung function in rodent-sensitized asthmatics. 
There is inadequate or insufficient evidence to determine 
whether or not an association exists between exposure to 
rodents (wild or as pets) in the home and exacerbation of 
symptoms or lung function in rodent-sensitized asthmatics.
There is sufficient evidence of a causal association between exposure to 
rodents in a laboratory setting and exacerbation of symptoms or lung 
function in rodent-sensitized asthmatics. 
There is limited or suggestive evidence of an association between 
exposure to rats or mice in the home and increased exacerbation or 
severity of asthma in rodent-sensitized asthmatic children.
Cow and horse allergens (acute, 
nonoccupational)
There is inadequate or insufficient evidence to determine 
whether or not an association exists between cow or horse 
allergen in the home and the exacerbation of asthma in 
sensitive children.
There is inadequate or insufficient evidence to determine whether or not 
an association exists between cow or horse allergen in the home and 
the exacerbation of asthma in sensitive children.
Endotoxins (low level) There is inadequate or insufficient information to determine 
whether or not an association exists between low-level indoor 
endotoxin exposure and exacerbation of asthma.
There is sufficient evidence of an association between indoor endotoxin 
exposure and the exacerbation of asthma.
Houseplants (+ cut flowers) There is inadequate or insufficient evidence to determine 
whether or not an association exists between exposures from 
houseplants and the exacerbation of asthma.
There is inadequate or insufficient evidence to determine whether or not 
an association exists between exposures from houseplants and the 
exacerbation of asthma.
Pesticides (residential, 
nonoccupational)
There is inadequate or insufficient evidence to determine whether 
or not an association exists between pesticide exposures at the 
levels typically encountered in non-occupational or residential 
settings and the exacerbation of asthma.
There is inadequate or insufficient evidence to determine whether or 
not an association exists between pesticide exposures at the levels 
typically encountered in nonoccupational or residential settings and 
the exacerbation of asthma.
Plasticizers (nonoccupational) There is inadequate or insufficient evidence to determine 
whether or not an association exists between nonoccupational 
exposure to plasticizers and the exacerbation of asthma.
There is inadequate or insufficient evidence to determine whether 
or not an association exists between nonoccupational exposure to 
plasticizers and the exacerbation of asthma.
Volatile organic compounds (VOCs) 
(residential, other than 
formaldehyde) 
There is inadequate or insufficient evidence to determine 
whether or not an association exists between indoor 
residential VOC exposures and the exacerbation of asthma.
There is inadequate or insufficient evidence to determine whether or not 
an association exists between indoor residential VOC exposures (other 
than formaldehyde) and the exacerbation of asthma.
Pollen indoors There is inadequate or insufficient evidence to determine 
whether or not an association exists between pollen exposure 
in the indoor environment and the exacerbation of asthma.
There is inadequate or insufficient evidence to determine whether 
or not an association exists between pollen exposure in the indoor 
environment and the exacerbation of asthma.
Down/feather bedding or synthetic 
bedding
There is inadequate or insufficient evidence to determine 
whether or not an association exists between down pillows 
and exacerbation of symptoms or lung function in asthmatics. 
Down pillows are believed to be a risk factor for asthma 
because of their documented mite content, rather than 
because of the presence of bird allergen.
There is limited or suggestive evidence that down/feather bedding 
may be protective for various respiratory effects relative to synthetic 
bedding, presumably due to lower content of dust mites, although 
evidence is not available regarding exacerbation of asthma.
Low outdoor air ventilation rate There is inadequate or insufficient information to determine 
whether an association exists between lower ventilation rates 
and the exacerbation of asthma symptoms.
There is inadequate or insufficient evidence to determine whether an 
association exists between lower ventilation rates in buildings and the 
exacerbation of asthma.
ETS, environmental tobacco smoke. Exposures excluded from this review included all infectious agents (e.g., Chlamydia pneumoniae, Chlamydia trachomatis, Mycoplasma 
pneumoniae, respiratory syncytial virus) and all outdoor-generated pollutants (e.g., ozone, sulfur dioxide, nitrogen dioxide, nonbiologic particles). Kanchongkittiphon et al.
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No new controlled exposure studies were 
identified, but those cited by the IOM (2000) 
provided strong evidence confirming causality 
in sensitized adults (Bernton et al. 1972; 
Kang 1976). In children, controlled exposure 
studies have not been available. Prospective 
findings in children have been uniformly 
positive. For prospective studies, the one 
recent and one prior study, in specifically 
sensitized children, both found associations 
of bedroom cockroach allergen with increased 
asthma morbidity: allergen in bedroom floor 
and bed dust with significantly more asthma 
symptom days, school days missed, and 
caretaker­interrupted sleep in Gruchalla et al. 
(2005), and allergen in bedroom floor dust 
with more than three times the rate of hospi­
talization in Rosenstreich et al. (1997). 
In contrast, cross­sectional findings in 
children on bedroom cockroach allergen, all 
recent, have been mixed. Gent et al. (2009) 
found no associations of cockroach allergen 
in beds with asthma severity in children with, 
or those without, specific sensitization. This 
study, however, had two limitations: Allergen 
levels were very low, with only 4% of children 
exposed at > 2 μg/g of dust, the level with 
increased risk in Gruchalla et al. (2005), 
compared with 35% in that study, and dust 
samples were taken only from beds, whereas 
all positive studies included bedroom floor 
dust. In children of unknown atopic status, 
Turyk et al. (2006) found strong, dose­
related associations of cockroach allergen in 
bedroom floor and bed dust with number 
of symptoms, with odds ratios (ORs) up 
to 5.8, but Spanier et al. (2006) found no 
associa  tions of allergen in bedroom floor dust 
with FeNO. 
For cross­sectional findings on cock­
roach allergen measured in kitchens, Rabito 
et al. (2011) reported strong associations 
(ORs > 4) with hospital admissions in both 
those with and those without specific sensi­
tization. In cross­sectional findings based on 
other exposure assessments, neither of the 
two reports on measured cockroach antigens 
in living rooms found associations with 
exacer  ba  tion of asthma (Gent et al. 2009; 
Turyk et al. 2006); and neither of the two 
studies on visible cockroach presence in 
homes found associations with exacer  ba  tion 
of asthma: with asthma symptoms, unsched­
uled medical visits, or steroid use for asthma 
attacks (Bonner et al. 2006), and with asthma 
symptoms (Shedd et al. 2007).
The strong association of cockroach 
allergen with severe effects in both sensitized 
and nonsensitized children in one study 
(Rabito et al. 2011) might be attributable to 
irritant effects or non­IgE–mediated sensiti­
zation mechanisms. Cockroach allergen can 
induce mucosal allergic sensitization and 
inflammation via PAR­2 (Jeong et al. 2008), 
induce expression of inflammatory cytokine 
(e.g., IL­8, IL­6), and trigger innate immune 
response in the human airway epithelium 
(Kauffman 2006; Matsumura 2012). These 
findings suggest a potential mechanism for 
cockroach allergen­induced asthma morbidity 
in sensitized and nonsensitized subjects.
The overall evidence demonstrates that 
exposure to cockroach antigen causes exacer­
ba  tion of asthma in specifically sensitized 
adults, but such evidence is less consistent for 
children. For specifically sensitized children, 
the strongest studies, the two prospective, 
consistently show associations with measured 
allergen exposures in bedrooms, which may 
be a critical location for exposure. Although 
cross­sectional findings for bedroom dust are 
mixed, the only one with negative findings 
for sensitized children had very low exposure 
levels. Other cross­sectional study findings 
are limited but positive for kitchen exposures, 
and negative for exposures in living rooms or 
as assessed by visible cockroaches in homes. 
A few reported associations are strong (Rabito 
et al. 2011; Rosenstreich et al. 1997; Turyk 
et al. 2006), including a strong finding in 
nonsensitized children, and dose–response 
findings are available from one study (Turyk 
et al. 2006). The most reasonable conclusion is 
still of a causal relationship in both adults and 
children, although the evidence in children is 
weaker. Strong study designs and improved 
exposure assessment may be key to future 
demonstration of health risks associated with 
cockroach allergen.
Conclusions.
• There is sufficient evidence of a causal 
relationship between cockroach allergen 
exposure and exacer  ba  tion of asthma in 
individuals specifically sensitized to cock­
roaches, especially adults.
• There is limited or suggestive evidence of 
association between cockroach allergen 
exposure and exacer  ba  tion of asthma in 
children not sensitized to cockroaches.
Environmental tobacco smoke exposures. 
Background. A substantial body of research 
has assessed the respiratory health effects 
of involuntary exposure to environmental 
tobacco smoke (ETS). Tobacco smoke 
contains solid particles and semivolatile 
and volatile organic compounds. These 
compounds include known or suspected eye 
and respiratory irritants, toxicants, mutagens, 
and carcinogens (Zeise and Dunn 1999). 
Distinguishing the effects of acute versus 
chronic ETS exposure is challenging, except 
by controlled chamber studies, which have 
been conducted only in adults (IOM 2000). 
Therefore, all observational studies are consid­
ered to assess chronic ETS exposure. The 
IOM concluded:
• There is sufficient evidence of a causal 
relation  ship between chronic ETS exposure 
and exacer  ba  tions of asthma in preschool­
age children.
• There is limited or suggestive evidence of a 
relationship between chronic ETS exposure 
and exacer  ba  tions of asthma in older 
children and adults.
• There is limited or suggestive evidence of an 
association between acute ETS exposure and 
exacer  ba  tion in asthmatics sensitive to this 
exposure (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S5 summarizes 
19 recent studies on ETS exposure and exacer­
ba  tion of asthma: in preschool­age children, 
two prospective studies; in older children, 
three prospective, one case–control, and eight 
cross­sectional studies; in adults and children, 
one prospective and one cross­sectional study, 
and in adults, three prospective studies. Some 
new findings have failed to show a relationship 
between ETS and   exacer  ba  tion of asthma.
In preschool­age children, Kattan et al. 
(2007) found that high ETS exposures were 
not significantly related to increased wheeze or 
unscheduled medical visits, though they were 
associated with decreased peak flow in cold 
weather. Perzanowski et al. (2010) reported 
that, although previous ETS exposure was 
positively associated with FeNO, current 
exposure was inversely related to FeNO. ETS 
exposure at 4 years of age was associated with 
significantly lower FEV1 and forced expira­
tory flow in mid 50% of exhaled volume 
(FEF25–75%) at 7 years, but not concurrent 
exposure at 7 years.
In older children with asthma, FeNO was 
not associated with reported tobacco smoke 
exposure, serum cotinine, or hair cotinine 
(Dinakar et al. 2005; Spanier et al. 2006, 
2008). In fact, measured nicotine exposure 
was associated with decreased FeNO (Spanier 
et al. 2008), a response possibly mediated 
by a NOS3 genetic polymorphism (Spanier 
et al. 2009). Glutathione S­transferase gene 
variants have also been implicated in lung 
function response to ETS (Palmer et al. 
2006). This may indicate that ETS does not 
cause allergic airway inflammation. Other 
recent studies demonstrate no difference 
in acute asthma symptoms or responses to 
emergency therapy by ETS exposure (Karadag 
et al. 2003; Vargas et al. 2007).
In contrast, many studies in children have 
continued to demonstrate associations of 
ETS with reduced lung function, increased 
wheezing, nocturnal symptoms, and emer­
gency department visits (Chapman et al. 
2003; Lawson et al. 2011; Morkjaroenpong 
et al. 2002; Soussan et al. 2003; Sturm et al. 
2004; Wang et al. 2007). Ecologic evidence 
presented by Herman and Walsh (2011) on 
adults and children demonstrated 22% lower 
hospital admission rates for asthma after a 
smoking ban in Arizona, compared with rates Indoor exposures and exacerbation of asthma
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in counties without bans. In adults, Eisner 
et al. (2002, 2005) demonstrated that ETS 
exposure was associated with greater asthma 
severity during follow­up, emergency depart­
ment visits, and hospital admissions for 
asthma. Newman et al. (2010) reported that 
home ETS exposure had a nonsignificant 
association with reduced severity or frequency 
of symptoms during pregnancy.
Overall, regarding ETS and exacer  ba­
tion of asthma in preschool­age children, 
the basis for the prior IOM conclusion of 
demonstrated causality is not clear. The two 
recent prospective studies in preschool­age 
children (Kattan et al. 2007; Perzanowski 
et al. 2010) have not found the clear relation­
ships expected from a causal relationship. The 
overall evidence now, not fully consistent, 
seems to better support a finding of an asso­
ciation rather than of causality for preschool­
age children. For older children and adults, 
available evidence is very inconsistent 
regarding association of ETS with increased 
asthma morbidity. This is in agreement with 
the prior assessment of limited or suggestive 
evidence of a relationship. No additional 
recent evidence was identified regarding acute 
ETS exposure and exacerbation of asthma.
Conclusions.
• There is sufficient evidence of an association 
between chronic ETS exposure and exacer­
ba  tions of asthma in preschool­age children.
• There is limited or suggestive evidence of an 
association between chronic ETS exposure 
and exacer  ba  tions of asthma in older 
children and adults.
• There is limited or suggestive evidence of 
an association between acute ETS exposure 
and exacer  ba  tion of asthma in asthmatics 
sensitive to this exposure.
Exposures for which Sufficient Evidence 
Had Existed for an Association with 
Exacerbation of Asthma
Dog allergens. Background. Two major 
dog allergens, Can f 1 and Can f 2, have 
been identified. High levels of dog dander 
have been found in homes with dogs and in 
homes and buildings without resident dogs, 
and positive bronchial provocation tests with 
dog allergen have been correlated with sensi­
tization to dog allergen (IOM 2000). The 
IOM concluded:
• There is sufficient evidence of an association 
between dog allergen exposure and exacer­
ba  tion of asthma in individuals specifically 
sensitized to dog allergen (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S6 summarizes 
the findings of five recent available studies: 
in children, three prospective and one cross­
sectional, and in adults, one cross­sectional.
McConnell et al. (2006) found that the 
presence of dogs in homes increased the 
effect of ambient pollutants on bronchitic 
symptoms in asthmatic children not assessed 
for specific sensitization. Two other prospec­
tive studies and the cross­sectional study 
found that exposure to dog allergens signifi­
cantly increased asthma severity in sensitized 
children (Gent et al. 2009, 2012; Murray 
et al. 2006). In adults, nonsensitized subjects 
exposed to high levels of dog allergens also 
demonstrated increased airway reactivity 
(Langley et al. 2005).
Prior evidence was sufficient only to 
suggest but not (as the IOM concluded) to 
establish associations between indoor dog 
allergen exposure and exacer  ba  tion of asthma. 
The addition of current findings establishes 
an association of dog allergen exposure 
to exacer  ba  tion of asthma in sensitized 
children, and also suggests associations in 
 nonsensitized  adults.
Conclusions.
• There is sufficient evidence of an asso­
ciation between dog allergen exposure 
and exacer  ba  tions of asthma in children 
sensitized to dogs.
• There is limited or suggestive evidence 
of an association between dog allergen 
exposure and exacer  ba  tions of asthma in 
non sensitized  adults.
Fungi (quantified). Background. In this 
section we review studies of quantified fungal 
exposures as triggers of asthma. Effects of 
qualitatively assessed environmental fungi or 
of fungal components, fungal by­products, or 
other dampness­related agents are reviewed 
in the next section, “Dampness or dampness­
related agents.”
Sensitization to many fungal species that 
occur outdoors and indoors has long been 
documented, but the mechanisms under­
lying the responses to most fungi have not 
been fully defined. Increased asthma severity 
with higher outdoor fungal spore concen­
trations, provocation of asthma symptoms 
among patients with fungal sensitivities, and 
reduction in asthma symptoms by desensitiza­
tion with fungal antigens have been demon­
strated repeatedly (IOM 2000). However, 
links between measured indoor fungal 
concentrations and exacer  ba  tion of asthma, 
including relevant exposure parameters 
and mechanisms, have been less clear. The 
IOM concluded:
• There is sufficient evidence of an associa­
tion between fungal exposure and symptom 
exacer  ba  tion in sensitized asthmatics. 
Exposure may also be related to nonspecific 
chest symptoms (IOM 2000).
Summary of new evidence. The studies 
previously cited by the IOM (2000), in 
conjunction with Atkinson et al. (2006) and 
Pongracic et al. (2010), demonstrate that 
outdoor fungal exposures cause exacer  ba  tion 
of asthma in sensitized individuals. Atkinson 
et al. (2006), for instance, reported that 
outdoor fungal concentrations were positively 
related to children’s admissions to emergency 
rooms, after adjustment for pollen and air 
pollutants. The overall evidence documents 
strong association, temporality, consistency, 
and biologic plausibility, with dose­related 
response shown by Pongracic et al. (2010).
In the Supplemental Material, Table S7 
summarizes six studies providing recent 
evidence on indoor fungal exposure and 
exacer  ba  tion of asthma, all in children: five 
prospective and one cross­sectional. All 
findings described below, unless otherwise 
specified, refer to indoor culturable airborne 
fungal concentrations, measured in prospective 
studies in asthmatic children, with analyses 
adjusted for key confounding variables.
Two prospective studies found that in 
specifically sensitized children, culturable 
airborne indoor Penicillium was associated 
with significantly increased outcomes of severe 
exacer  ba  tions (as indicated by unscheduled 
medical visits), severity, or symptoms (Gent 
et al. 2012; Pongracic et al. 2010), even after 
adjustment for outdoor fungal levels in one 
study (Gent et al. 2012). Among children 
with any fungal sensitization but not neces­
sarily to the genus in question (26% were 
sensitized to Penicillium), Pongracic et al. 
(2010) found indoor culturable airborne 
Penicillium, and also the summed four most 
common fungal genera, to be associated 
with significantly increased severe exacer  ba­
tions and symptoms, and total indoor fungal 
concentration to be associated with signifi­
cantly increased severe exacer  ba  tions. Among 
those with any fungal sensitization, increases 
in symptom days associated with each specific 
genus were smaller among those not specifi­
cally sensitized than among those sensitized, 
although the decrease for Penicillium was only 
5% (Pongracic et al. 2010).
Among asthmatic children of unknown 
sensitization status, a cross­sectional study by 
Turyk et al. (2006) found indoor Penicillium 
to be associated with significantly increased 
symptom frequency, and a prospective 
study by Bundy et al. (2009) found indoor 
Penicillium, but not total indoor fungi, to 
be associated with significantly increased 
peak expiratory flow variability (PEFV). 
In contrast, in unadjusted analyses from a 
small study of 19 children, Inal et al. (2007) 
found no significant associations between 
total indoor molds or four specific genera 
including Penicillium, and symptom or 
lung function outcomes; limitations of this 
study reduce its importance. An important 
weakness of these studies on airborne cultur­
able fungi is that all those specifying their 
sampling methods used 1­min air samples, 
and thus had highly unreliable estimates 
of fungal concentrations, which have high Kanchongkittiphon et al.
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temporal variability. In unadjusted analyses 
in children of unspecified atopic status, Wu 
et al. (2010) found that total culturable fungi 
in dust were associated with an increased 
number of urgent care visits only in those 
with genetic polymorphisms that caused 
reduced enzymatic breakdown of chitin, 
an important fungal protein. (This study 
provides biologic plausibility for nonallergic 
mechanisms for exacer  ba  tion of asthma in 
relation to fungal exposures.)
The overall available evidence is sufficient 
to document that asthma exacer  ba  tion is 
caused by outdoor fungal exposures in those 
sensitized. Although these outdoor fungi 
also occur indoors, the evidence is not suffi­
cient to demonstrate causality or association 
directly from indoor fungal exposures. The 
associations reported for Penicillium may be 
attributable to confounding by other indoor 
dampness­related exposures.
Conclusions.
• There is sufficient evidence of a causal asso­
ciation between outdoor culturable fungal 
exposure and exacer  ba  tion in asthmatics 
sensitized to fungi.
• There is limited or suggestive evidence of 
an association between indoor culturable 
Penicillium exposure and exacer  ba  tion in 
asthmatic children with specific sensitiza­
tion, any fungal sensitization, or unspecified 
sensitization.
• There is limited or suggestive evidence of an 
association between indoor total culturable 
fungal exposure and exacer  ba  tion of asthma 
in children with any fungal sensitization.
Dampness or dampness-related agents. 
Background. Sufficient evidence has long 
been available to document associations 
between indicators of dampness and exacer­
ba  tion of asthma and other respiratory effects. 
The specific dampness­related causal agents, 
although not identified, were assumed to be 
dust mite or fungal allergens (IOM 2000). 
The few available studies showed fairly consis­
tent, strong associations between dampness 
indicators in buildings and exacer  ba  tion of 
asthma. The prior IOM conclusion did not 
clearly specify if evidence demonstrated 
causality or only association:
• Dampness may exacerbate existing asthma. 
The factors related to dampness that actually 
lead to the development of disease and to 
disease exacer  ba  tion are not yet confirmed, 
but probably relate to dust mite and fungal 
allergens (IOM 2000).
Summary of new evidence. Eight studies 
on qualitative assessments of dampness indica­
tors (e.g., visible dampness, water damage, or 
mold, or mold odor) or quantified dampness 
and exacer  ba  tion of asthma have become avail­
able or were not previously considered. In the 
Supplemental Material, Table S8 summarizes 
evidence from these eight studies: in children, 
two controlled intervention, two prospective, 
and two cross­sectional studies; and in adults, 
one prospective and one cross­sectional study.
Kercsmar et al. (2006), in a controlled 
intervention study in damp houses of asth­
matic children, reported that comprehensive 
remediation of dampness sources and visible 
mold caused dramatic reductions in severe 
exacer  ba  tion of asthma. Acute care visits 
after remediation were significantly reduced 
(by 90%) in the children in homes actually 
receiving remediation (i.e., as treated) 
compared with those in the control homes. 
Another intervention study (Bernstein 
et al. 2006) and two prospective studies 
(Hagmolen of Ten Have et al. 2007; Venn 
et al. 2003) in children found significant 
positive associations between dampness or 
mold and exacer  ba  tion or severity of asthma 
outcomes. Bernstein et al. (2006) performed 
a controlled intervention in which ultra­
violet radiation was applied in home venti­
lation ducts to reduce microbial exposures 
to fungally sensitized asthmatic children. 
Ultraviolet radiation was associated with a 
significant reduction in PEFV and a nonsig­
nificant reduction in FEV1; with significant 
reductions in severity scores for shortness of 
breath and chest tightness, in number of days 
of shortness of breath and chest tightness, 
and in amount of medication used; and with 
nonsignificant reductions in all other disease 
severity measures (Bernstein et al. 2006). The 
presumed mechanism is reduction of unspeci­
fied microbial exposures. The intervention 
study by Burr et al. (2007) was considered 
ineligible because its intervention for mold 
removal also increased outdoor air ventilation, 
which reduces concentration of other indoor 
airborne contaminants, thus making the study 
benefits not specific to mold removal.
Venn et al. (2003) reported a dose­
related positive association of measured wall 
moisture with wheezing in children with 
persistent wheezing over 3 years, significantly 
more in atopic cases. ORs for measured 
bedroom moisture and nighttime symptoms, 
and measured living room moisture and 
daytime symptoms, both showed dose­
related responses, with ORs ranging up to 
7.0 for the highest moisture level. Visible 
mold was not significantly associated with 
either symptom type, but was significantly 
associated with presence of wheezing illness. 
Hagmolen of Ten Have et al. (2007) reported 
that damp stains or mold growth were 
significantly positively associated with three 
asthma severity metrics. Only one­third of the 
subjects were fungally sensitized.
Of two cross­sectional studies in children, 
Bonner et al. (2006) found strong positive 
associations between home moisture or mold 
and three asthma severity metrics, but Teach 
et al. (2006) found no such relationships. 
Bonner et al. (2006) reported the presence 
of moisture or mildew at home to be associ­
ated with more than three times the hospital 
visits for breathing­related problems, more 
than three times the frequency of wheezing 
episodes, and more than twice the expected 
frequency of night symptoms. Teach et al. 
(2006) reported that visible dampness or mold 
in the home during the previous month was 
not associated with unscheduled medical care 
visits above the median, persistent asthma 
symptoms, or quality­of­life scores below 
the median.
In adults, a prospective study found 
a doubling in asthma attacks with home 
mold exposure (Wen et al. 2009), regard­
less of subject obesity. A cross­sectional study 
in diagnosed asthmatics, previously cited 
by IOM (2000), found that both moisture 
meter–measured total home dampness and 
visible mold score had significant positive 
dose­related associations with asthma severity, 
and higher measured dampness was associated 
with significantly greater measured airflow 
obstruction (Williamson et al. 1997).
The specific causal agents for exacer­
ba  tions of asthma that are associated with 
dampness have not been identified. Although 
it is often assumed that these agents are 
fungal, they may include other biologic expo­
sures such as bacteria, amoebas, or dust mites 
that thrive in dampness, or nonbiologic expo­
sures such as chemicals emitted from damp 
materials (Mendell et al. 2011).
In these studies, evident dampness or 
mold or measured dampness was posi­
tively associated—with almost complete 
consistency—with exacer  ba  tion or severity 
of asthma. The intervention studies, which 
had the strongest designs, both showed 
these relationships clearly. The intervention 
and prospective studies, both demonstrating 
temporality of effects, were consistent, as 
were all but one of the cross­sectional studies. 
Both Venn et al. (2003) and Williamson et al. 
(1997) showed strong, dose­related positive 
associations between measured moisture and 
asthma severity outcomes. Because of the 
implausibility of noncausal explanations for 
all these findings, especially those of Kercsmar 
et al. (2006), this evidence indicates a causal 
association between indoor dampness or 
dampness­related agents and exacer  ba  tion of 
asthma in children with asthma. Few of the 
populations in these studies were restricted 
to atopic subjects, much less to those sensi­
tized to any fungi, specific fungal genera, or 
dust mites.
Conclusion.
• There is sufficient evidence of a causal asso­
ciation between dampness or dampness­
related agents and exacer  ba  tion of asthma 
in children, and of an association in adults. 
The evidence does not suggest that this Indoor exposures and exacerbation of asthma
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relationship is restricted to those with 
specific sensitization to fungi or dust mites.
Nitrogen dioxide. Background. Nitrogen 
dioxide (NO2) is a common pollutant gas 
found indoors and outdoors. It is produced, 
along with other oxides of nitrogen, whenever 
high­temperature combustion occurs. Indoor 
combustion sources, including gas stoves and 
space heaters, kerosene space heaters, and 
poorly vented furnaces and fireplaces, produce 
high indoor NO2 concentrations. Individual 
NO2 exposures in homes equipped with 
combustion appliances are usually driven by 
concentrations generated indoors even when 
elevated outdoor levels infiltrate into the 
home. Indoor NO2 levels in homes equipped 
with gas stoves are higher in kitchens than 
in other rooms and greatly higher during 
cooking. Thus, individual exposure in a home 
depends heavily on the amount of time spent 
in the kitchen during cooking (IOM 2000).
In addition to nitrogen oxides, indoor 
combustion appliances generally emit a 
variety of other pollutants such as carbon 
monoxide, sulfur dioxide (SO2), formalde­
hyde, volatile organic compounds (VOCs), 
and submicron particulate matter (PM), 
some of which are known respiratory irri­
tants. Epidemiologic studies generally have 
used only the presence of gas appliances as 
an indicator of elevated indoor NO2, or have 
measured NO2 but not other gas combustion 
emissions. Such studies thus have not been 
able to attribute health effects associated with 
gas appliances, or even with measured NO2, 
to NO2 exposure itself (IOM 2000). Brief, 
controlled high­level NO2 exposures, such as 
might be found in poorly ventilated kitchens 
during gas appliance use, caused enhanced 
airway responsiveness in asthmatic adults 
(IOM 2000). The IOM concluded:
• There is sufficient evidence of an asso­
ciation between brief high­level exposures 
to NO2 and increased airway responses 
to both nonspecific chemical irritants and 
inhaled allergens among asthmatic subjects. 
These effects have been observed in human 
chamber studies at concentrations that may 
occur only in poorly ventilated kitchens 
with gas appliances in use (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S9 summa­
rizes recent evidence from eight studies of 
NO2 and exacer  ba  tion of asthma: in children, 
two controlled intervention, four prospec­
tive cohort, and one cross­sectional study; 
and in adults, one prospective study. In the 
Supplemental Material, Table S10 summa­
rizes the evidence from six studies of gas stove 
use and exacer  ba  tion of asthma: in children, 
three cross­sectional, and in adults, two 
prospective and one cross­sectional study.
For NO2 studies in children, the two 
intervention studies (Gillespie­Bennett 
et al. 2011; Pilotto et al. 2004) replaced 
unflued gas heaters that emitted NO2 and 
other combustion products indoors. Either 
unreplaced gas heaters or higher NO2 were 
associated with increased asthma symptoms 
(Gillespie­Bennett et al. 2011; Pilotto et al. 
2004) and/or reduced FEV1 (Gillespie­
Bennett et al. 2011). In prospective studies, 
higher indoor NO2 indoors was associated 
with increases in many but not all measures 
of asthma­related morbidity (Belanger et al. 
2013; Fu et al. 2012; Hansel et al. 2008; 
Kattan et al. 2007). In the study by Belanger 
et al. (2013), four outcomes had significant 
dose­related increases. However, in one study, 
this association was found for wheeze only 
in nonatopic children (Kattan et al. 2007). 
Fu et al. (2012) found high NO2 exposures 
associated with more severe asthma in children 
with high beta­2­adrenergic receptor (ADRB2) 
gene methylation. In a cross­sectional study, 
Belanger et al. (2006) found that measured 
NO2 concentrations had a significant 
positive association with increased likeli­
hood of wheeze and chest tightness among 
asthmatic children in multi­family housing, 
but not in single­family housing. In adults, 
a prospective study (Ng et al. 2001) found 
adverse respiratory effects in asthmatic women 
associated with cooking­related measured 
NO2 exposures.
Regarding gas stove use, two cross­
sectional studies in children found associa­
tions with some but not all studied respiratory 
effects. Belanger et al. (2006) found that 
the presence of a gas stove in the home 
had a significant positive association with 
wheeze, shortness of breath, and chest tight­
ness among children living in multi­family 
housing, but not single­family housing. 
Chapman et al. (2003) found that use of 
a gas stove in the home for cooking had a 
significant inverse relationship on FEF25–75%, 
FEF25–75%/forced vital capacity (FVC), FEV1, 
and FEV1/FVC among girls who did not take 
prescription respiratory medication. There 
was no association among girls when respira­
tory medication was taken, and no association 
at all among boys. Use of an exhaust fan had 
no influence on the effects of using a gas stove 
(Chapman et al. 2003). Bonner et al. (2006) 
found that the presence of a gas stove not 
equipped with an outside vented exhaust was 
not associated with any measure of asthma 
severity related to symptoms, missed school, 
unscheduled health care visits, or steroid­
treated asthma attacks.
Studies of gas cooking in adults included 
two prospective cohort studies and one cross­
sectional study. Ng et al. (2001), in a prospec­
tive study, found adverse respiratory effects 
in asthmatic women from both short­term 
and repeated cooking exposures. Eisner et al. 
(2002) reported from a prospective study that 
personal use of a gas stove for cooking was 
not associated with asthma severity score, use 
of systemic corticosteroids or other asthma 
medications, or a history of hospitalizations 
and intubations. In a cross­sectional study, 
Eisner and Blanc (2003) reported that gas 
stove use had no significant association with 
FEV1, FVC, FEV1/FVC ratio, or FEF25–75% 
and no association with chronic cough or 
phlegm production. Gas stove use was related 
to a greater risk of dyspnea, wheeze, and any 
respiratory symptom, although those relation­
ships were not statistically significant (Eisner 
and Blanc 2003).
The overall available evidence leaves 
unchanged, due to lack of new evidence, the 
IOM (2000) conclusion about brief high­level 
NO2 exposures in asthmatics. Substantial new 
evidence, although not fully consistent, shows 
associations between indoor NO2 exposure 
and exacer  ba  tion of asthma. Conclusions on 
this relationship are further limited by the fact 
that many other unmeasured combustion­
related chemical and particulate compounds 
are emitted by gas stoves and heaters that may 
be related to asthma morbidity. Evidence 
for this relationship is thus considered to be 
only suggestive. Findings on gas stove use and 
exacer  ba  tion of asthma are too inconsistent to 
demonstrate associations.
Conclusions.
• There is sufficient evidence of an association 
between brief high­level exposures to NO2 
and increased airway responses to nonspe­
cific chemical irritants and inhaled allergens 
among asthmatic subjects.
• There is limited or suggestive evidence of an 
association between NO2  and  exacer ba tion 
of asthma, although this association may be 
attributable to confounding by other consis­
tently correlated emissions from gas stoves.
• There is inadequate or insufficient evidence 
to determine whether an associa  tion 
exists between gas stove use and exacer  ba­
tion of asthma.
Exposures for which Limited or 
Suggestive Evidence had Existed 
for an Association with Exacerbation 
of Asthma
Domestic birds. Background. Respiratory 
allergies to birds have been known to occur 
among zoo keepers and pet shop workers, but 
specific links between exposures and exacer­
ba  tions of asthma have not been made. The 
IOM review found that, although asthmatic 
symptoms had been documented in association 
with bird­keeping, specific bird antigens associ­
ated with allergies and asthma had not been 
identified and available evidence was lacking.
There was an assumption that feather 
bedding was associated with exacerbation of 
asthma because of mites associated with birds, 
but no supportive evidence was found. The Kanchongkittiphon et al.
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IOM report cited only one epidemiologic 
study, which found increased risk of wheeze 
in children using foam rather than feather 
pillows, and theorized that this unexpected 
association might result from bias due to 
parental replacement of feather bedding by 
synthetic bedding for symptomatic children 
(Strachan and Carey 1995). The IOM review 
also cited findings of higher dust mite antigen 
levels in synthetic pillows than in feather 
pillows and theorized the difference might 
result from more impermeable covers on 
feather bedding preventing infestation (IOM 
2000). The IOM review concluded
• There is limited or suggestive evidence of 
an association between bird exposure 
and exacerbation of symptoms in bird­
sensitized asthmatics. This association may 
be confounded by the allergic asthmatic 
response to mites harbored by birds.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between down pillows and exacerba­
tion of symptoms or lung function in 
asthmatics. Down pillows are believed to be 
a risk factor for asthma because of their docu­
mented mite content, rather than because of 
the presence of bird allergen (IOM 2000).
Summary of new evidence. No addi­
tional evidence was available on exposure to 
domestic birds and exacerbation of asthma 
over the past decade. Evidence continues to 
suggest that occupational exposure is asso­
ciated with the development of antibodies 
to feathers from specific birds (Renström 
et al. 2011; Swiderska­Kielbik et al. 2011), 
but that allergic responses may also occur to 
mites harbored by birds (Rimac et al. 2010). 
Down/feather bedding is discussed as a 
separate exposure, below.
Conclusion. 
• There is limited or suggestive evidence of 
an association between exposure to birds 
and the exacerbation of symptoms in bird­
sensitized asthmatics. This association may 
be confounded by the allergic asthmatic 
response to mites harbored by birds. 
Formaldehyde (nonoccupational). 
Background. Formaldehyde, an aldehyde 
and VOC, is emitted from many building 
materials, items of furniture, and consumer 
products, and by combustion processes 
including those in gas stoves and tobacco 
smoking. Cigarette smoke is considered to be 
one of the largest indoor sources of formalde­
hyde. The strongest sources have been urea–
formaldehyde foam insulation (no longer used) 
and various composite wood products made 
with urea­formaldehyde resins. Formaldehyde 
is also present in outdoor air, where motor 
vehicle exhaust is a major source. Indoor 
concentrations are determined by the presence, 
number, and age of sources, modified by the 
rate of outdoor air ventilation. Formaldehyde 
concentrations are generally highest in newly 
constructed or renovated building spaces and 
in areas that contain new furnishings made 
with formaldehyde resins (IOM 2000).
High­level exposure to formaldehyde 
has been documented to cause occupational 
asthma, although whether this occurs through 
immunologic or irritant mechanisms has 
been unclear. Little evidence was available 
related to effects of residential exposures on 
exacerbation of asthma (IOM 2000). The 
IOM concluded:
• There is limited or suggestive evidence of 
an association between formaldehyde 
exposure and wheezing and other respira­
tory symptoms (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S11 summa­
rizes the findings of two recent studies, both 
controlled exposure studies. In a blinded 
crossover study (Casset et al. 2006), exposure 
to 32 or 92 μg/m3 formaldehyde for 30 min 
had no effect on lung function or symptoms 
in asthmatic adults, but enhanced both 
immediate and late responses to dust mite 
antigen. Formaldehyde thus increased effects 
of a common asthma trigger without having 
apparent direct effects (Casset et al. 2006). 
A similar lack of lung function effect of 
500 μg/m3 formaldehyde exposure for 60 min 
was demonstrated in patients with intermit­
tent asthma (Ezratty et al. 2007). Although 
epidemiologic studies have shown associa­
tions of indoor formaldehyde exposures with 
asthma development and prevalent asthma in 
children (reviewed by McGwin et al. 2010), 
evidence on exacerbation of asthma was 
not available.
Conclusion.
• There is limited or suggestive evidence of 
an association between formaldehyde 
exposure and exacerbation of asthma, 
particularly through enhanced response to 
other allergens.
Exposure to certain fragrances (among 
sensitized individuals).  Background. 
Fragrances contain a variety of chemical 
compounds. Some asthmatics have been 
reported to have symptomatic responses to 
some scents. The few available controlled 
clinical challenge studies had inconsistent 
findings on respiratory effects of fragrance 
exposure in sensitive populations, and many 
studies failed to control for the possible 
influence of odor perception. Based on 
the studies that did account for odor, the 
IOM concluded:
• There is limited or suggestive evidence of 
an association between exposure to certain 
fragrances and the manifestation of respira­
tory symptoms in asthmatics sensitive to 
such exposures (IOM 2000).
Summary of new evidence. No recent 
studies were identified.
Conclusion.
• There is limited or suggestive evidence of 
an association between exposure to certain 
fragrances and the manifestation of respira­
tory symptoms in asthmatics sensitive to 
such exposures.
Exposures for which Inadequate or 
Insufficient Evidence Had Existed 
to Determine an Association with 
Exacerbation of Asthma
Rodent allergens. Background. Although 
several mouse and rat allergens have been 
identified, these may not be the key allergens 
for all species potentially present in the home 
(IOM 2000). Work­related allergies to rats 
or mice are well documented, but clear asso­
ciations between rodent exposures in homes 
and exacerbation of asthma had not been 
  established. The IOM concluded:
• There is sufficient evidence of an association 
between exposure to rodents in a laboratory 
setting and exacerbation of symptoms or 
lung function in rodent­sensitized asthmatics.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between exposure to rodents (wild 
or as pets) in the home and exacer  ba  tion 
of symptoms or lung function in rodent­
sensitized asthmatics (IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S12 summa­
rizes three available recent studies, all in 
children: one environmental intervention, 
one prospective, and one cross­sectional.
Pongracic et al. (2008), in a controlled 
environmental intervention study that 
removed mouse allergens from the homes of 
inner­city children with asthma and sensitiza­
tion to mouse or rat allergen, did not find 
a decrease in asthma symptoms or health 
care utilization to be associated during the 
intervention year with mouse allergen reduc­
tion. They did, however, report signifi­
cantly reduced school absenteeism, nights 
of child and caretaker waking, and number 
of days on which caretakers had to change 
plans (Pongracic et al. 2008). The study by 
Pongracic et al. (2008) suggests a potential 
relationship between mouse allergen exposure 
in sensitized children and asthma severity or 
exacerbations. A prospective study on inner­
city asthmatic children found that mouse 
allergen exposure contributed significantly to 
sensitization, but, among mouse­sensitized 
children, only to several nonsignificant 
trends for measures of asthma morbidity 
(Phipatanakul et al. 2000). Bonner et al. 
(2006), in a cross­sectional study in children 
of unknown sensitization status, found no 
association between presence of rats or mice 
in the home and symptoms or unscheduled 
medical visits; however, because sensitiza­
tion status was unknown, this study does Indoor exposures and exacerbation of asthma
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not provide information about responses of 
rodent­allergic children.
The IOM (2000) had suggested that 
sufficient home exposures to rodent allergen 
among sensitized individuals might be 
expected to be associated with exacer  ba­
tion of asthma, but insufficient information 
was available on home exposures and on 
non  occupational sensitization. A reconsid­
eration of evidence previously considered 
by the IOM (2000) on occupational rodent 
exposure, which demonstrates strong, consis­
tent, temporally appropriate, and biologically 
plausible relationships, leads to a conclu­
sion of a causal relationship between occu­
pational rodent exposure and exacer  ba  tion 
of asthma in sensitized adult workers. Also, 
recent evidence shows a substantial minority 
of inner­city homes to have rodent allergen 
levels comparable with occupational settings, 
and also to have rodent­sensitized children 
(e.g., Matsui et al. 2005).
The two available studies on asthmatic 
response to rodent allergen among sensi­
tized children, a controlled intervention 
(Pongracic et al. 2008) and a prospective 
study (Phipatanakul et al. 2000), found either 
significant effects for several but not other 
outcomes, or small and not statistically signifi­
cant effects in only a few outcomes. These 
findings do not suggest a clear association. 
However, together with a determination that 
occupational rodent exposure causes exacer­
ba  tion of asthma in sensitized adult workers, 
and the recent findings about home exposure 
levels, these findings suggest possible asso­
ciations in populations of highly exposed, 
 sensitized  children.
Conclusions.
• There is sufficient evidence of a causal 
association between exposure to rodents 
in a laboratory setting and exacer  ba  tion 
of symptoms or lung function in rodent­
sensitized asthmatics.
• There is limited or suggestive evidence of 
an association between exposure to rats or 
mice in the home and increased exacer  ba  tion 
or severity of asthma in rodent­sensitized 
asthmatic children.
Cow and horse allergens (acute, 
non occupational  exposures). Background. 
Although occupational allergy to cows or 
horses has been well recognized, data for 
nonoccupational exposures have not been not 
readily available. In contrast, evidence has 
increasingly shown that living on farms with 
animals may protect children against develop­
ment of atopy and atopic asthma (IOM 
2000). The IOM concluded:
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between cow or horse allergen in the 
home and the exacer  ba  tion of asthma in 
sensitive children (IOM 2000).
Summary of new evidence. No recent 
studies were identified.
Conclusion.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between cow or horse allergen in the 
home and the exacer  ba  tion of asthma in 
sensitive children.
Endotoxins. Background. Endotoxins are 
compounds found in the outer membranes 
of gram­negative bacteria. These bacteria 
are associated with the presence of pets, 
rodents, and dampness or mold in homes. 
Toxic effects associated with endotoxins are 
considered to come from a specific endotoxin, 
lipopolysaccharide (LPS). Toxicologic and 
epidemiologic studies have demonstrated 
that endotoxins cause inflammatory and 
atopic responses in nonasthmatic and asth­
matic subjects, but are also associated with 
decreased atopy. Variations in the structure of 
the polysaccharide chain or its lipid portion 
in different bacteria, the route of exposure, 
dose rate, age at exposure, and atopic status 
all potentially influence the biological effects. 
Adverse effects from endotoxins were appar­
ently increased by other dampness­associated 
agents, and vice versa (IOM 2000). Because 
the available evidence supported predictions 
of either increased or decreased inflammatory 
responses in asthmatic individuals exposed to 
endotoxins, the IOM concluded::
• There is inadequate or insufficient infor­
mation to determine whether or not an 
association exists between low­level indoor 
endotoxin exposure and asthma   exacer  ba  tion 
(IOM 2000).
Summary of new evidence. In the 
Supplemental Material, Table S13 describes 
three recent studies available on endotoxins 
and exacer  ba  tion of asthma: in children, one 
cross­sectional study; in adults, one controlled 
challenge study; and in adults and children, 
one cross­sectional study. Two studies provide 
evidence associating elevated endotoxin 
levels with increased asthma severity and 
bronchial hyperresponsiveness (Rabinovitch 
et al. 2005; Thorne et al. 2005). Rabinovitch 
et al. (2005) measured personal daily endo­
toxin exposures of children in particulate 
fractions of PM ≤ 2.5 μm diameter (PM2.5) 
and ≤ 10 μm diameter (PM10). Endotoxin 
levels were related to clinically significant 
increases in asthma severity indices. Personal 
endotoxin exposures had a significant positive 
association with asthma symptom scores and 
with evening FEV1, but not with morning 
FEV1. Thorne et al. (2005) reported that 
endotoxin in bedroom floor dust was asso­
ciated with significantly elevated ORs for 
asthma symptoms, asthma medication use, 
and wheezing; similar but lower associations 
were found for bedding endotoxin concentra­
tions. No association of increased hay fever 
risk or protection was found. These effects 
of endotoxins were found in adults, but not 
children. The authors concluded that U.S. 
household endotoxin exposures are associated 
with asthma symptoms, current asthma medi­
cation use, and wheezing, but not with allergy 
(Thorne et al. 2005). Kitz et al. (2006) found 
that controlled inhalation challenge to LPS 
in asthmatic adults caused a significant fall 
in FEV1 90 min later, reaching a maximum 
after 120 min.
Among studies cited by the IOM (2000), 
two provided prior evidence linking indoor 
endotoxin exposures to exacerbation of 
asthma: Experimental endotoxin exposure 
increased bronchial responsiveness to hista­
mine among asthmatic adults, lasting 5 hr, 
but not among nonasthmatic adults (Michel 
et al. 1989); a cross­sectional study showed 
that endotoxin content of house dust was 
associated with increased asthma severity in 
dust mite–sensitized adults, but concentra­
tion of dust mite allergen was not (Michel 
et al. 1996). Overall, the evidence suggests 
that endotoxin exposure is associated with 
increased inflammation and asthma severity, 
but not increased allergy. In fact, a growing 
number of studies suggest that early­life 
microbiologic exposures to endotoxin may 
protect against later atopy (e.g., Illi et al. 2014; 
Lawson et al. 2012), although these exposures 
are also associated with increased wheeze 
(Celedon et al. 2007). This potentially protec­
tive effect is consistent with the “hygiene 
hypothesis,” which postulates that growing up 
in a microbially more hygienic and less diverse 
environment may increase risk of developing 
respiratory allergies (Heederik and von Mutius 
2012). In contrast, damp or moldy buildings, 
even though they are associated with increased 
endotoxin, seem only to increase, not decrease, 
the development of respiratory disease, even in 
infants (Mendell et al. 2011).
The available evidence shows a clear asso­
ciation of indoor endotoxin exposure with 
exacerbation among asthmatic individuals, 
regardless of whether early exposures prevent 
later development of allergies. With strong 
and consistent effects shown in epide­
miologic studies and controlled exposures, 
biologic plausibility for inflammatory effects, 
and appropriate temporal relationships, the 
evidence is close to documenting a causal rela­
tionship between endotoxin and exacerbation 
in asthmatics. However, the dual protective 
and adverse effects suggest caution in labeling 
indoor endotoxin simply as an adverse causal 
exposure. The roles of timing, dose, and 
circumstance of this protective response to 
exposure need to be better delineated.
Conclusion.
• There is sufficient evidence of an association 
between indoor endotoxin exposure and 
exacerbation of asthma.Kanchongkittiphon et al.
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Houseplants. Background. In theory, 
houseplants have the potential to release 
pollen, sap, and other plant parts, or to host 
pests or fungi that could release allergens, thus 
provoking allergic responses in people with the 
necessary sensitization (IOM 2000). Because 
no studies had been conducted to document 
these relationships, the IOM concluded:
• There is inadequate or insufficient evidence 
to determine whether or not an associa­
tion exists between exposures from house­
plants and the exacerbation of asthma 
(IOM 2000).
Summary of new evidence. No recent 
studies have addressed houseplant exposure.
Conclusion.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between exposures from houseplants 
and the exacerbation of asthma.
Pesticides.  Background. Pesticides 
include many kinds of fungicides, herbicides, 
insecticides, and rodenticides. Pesticides are 
reportedly used in > 80% of U.S. homes. 
Inhalation and dermal absorption are two 
potential routes of exposure to pesticides used 
in the home. The diversity of pesticides used 
in homes suggests that their relationships to 
exacerbation of asthma will not be uniform 
(IOM 2000). The IOM concluded:
• There is inadequate or insufficient evidence 
to determine whether or not an associa­
tion exists between pesticide exposures at 
the levels typically encountered in non­
occupational or residential settings and the 
exacerbation of asthma (IOM 2000).
Summary of new evidence. No recent 
data have directly addressed pesticides in 
relation to exacerbation of asthma. In a longi­
tudinal study in the Center for the Health 
Assessment of Mothers and Children of 
Salinas (CHAMACOS), increased T helper 2, 
asthma, and wheeze outcomes in children 
were associated with reported maternal work 
in agriculture, which may be an indirect indi­
cator of pesticide exposure to children, either 
prenatally or at home (Duramad et al. 2006).
Conclusion.
• There is inadequate or insufficient evidence 
to determine whether or not an associa­
tion exists between pesticide exposures 
at the levels typically encountered in 
non  occupational or residential settings and 
the exacerbation of asthma.
Plasticizers. Background. Plasticizers are 
chemicals that increase the flexibility of plastic 
resins. A major use of plasticizers is in poly­
vinyl chloride, widely used indoors in sheet 
vinyl flooring, wall coverings, vinyl uphol­
stery, and shower curtains. These products 
are major sources of plasticizer residues, such 
as di(2­ethylhexyl) phthalate (DEHP) in 
homes (IOM 2000). DEHP was associated 
with airway inflammation and possibly with 
asthma causation. Occupational exposure 
to plasticizers at high levels was also associ­
ated with exacerbation of asthma and asthma 
causation. The available evidence was very 
limited. The IOM review concluded
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between non  occupational exposure to 
plasticizers and the exacerbation of asthma 
(IOM 2000).
Summary of new evidence. Recent studies 
have demonstrated associations between the 
presence of plastic materials in homes and 
increased allergies, respiratory symptoms, 
and diagnosed asthma (Jaakkola and Knight 
2008; Jaakkola et al. 2000, 2006; Mendell 
2007), but have not evaluated effects on 
  exacerbation of asthma.
Conclusion.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between non  occupational exposure to 
plasticizers and the exacerbation of asthma.
VOCs other than formaldehyde. 
Background. Personal exposures to VOCs are 
dominated by indoor exposures, even in areas 
near major outside VOC sources. Hundreds 
of VOCs have been measured in indoor air, 
and their diversity suggests lack of uniformity 
in their potential associations with health. 
Buildings contain numerous sources of 
VOCs, including tobacco smoke, combustion 
appliances, building and renovation materials, 
house cleaning and maintenance products, 
solvents, photocopying machines, dry­cleaned 
clothes, personal care products, printed mate­
rials, room deodorizers, moth crystals, and 
chlorinated water. The main factors influ­
encing exposures are the presence of mate­
rials, emission rates, ventilation, and personal 
behavior (IOM 2000). Very limited evidence 
suggested any associations between exposures 
to VOCs indoors and exacerbation of asthma. 
The multiple correlations between the few 
studied compounds and many others, often 
unmeasured, made it difficult to implicate 
specific VOCs. The IOM review concluded
• There is inadequate or insufficient evidence to 
determine whether or not an association exists 
between indoor residential VOC exposures 
and the exacerbation of asthma (IOM 2000).
Summary of new evidence. Although 
some studies have suggested associations 
between indoor VOCs or semi­VOCs and 
respiratory or allergic effects (Arif and Shah 
2007; Choi et al. 2010; Mendell 2007; 
Rumchev et al. 2004), and between outdoor 
VOCs and exacerbation of asthma (Delfino 
et al. 2003), no new evidence related to 
exacer  bation of asthma by indoor VOCs 
other than formaldehyde was identified.
Conclusion.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between indoor residential VOC 
exposures (other than formaldehyde) and 
exacerbation of asthma.
Pollen exposures indoors. Background. 
The primary source of indoor pollen is infil­
tration from outdoors. Evidence of outdoor 
pollen in indoor dust samples suggests that it 
may be an important exposure for exacerba­
tion of asthma (IOM 2000). Because of lack 
of any direct evidence, the IOM concluded:
• There is inadequate or insufficient evidence 
to determine whether or not an associa­
tion exists between pollen exposure in the 
indoor environment and the exacerbation of 
asthma (IOM 2000).
Summary of new evidence. No recent 
evidence regarding indoor pollen exposure 
and exacerbation of asthma was identified.
Conclusion.
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between pollen exposure in the indoor 
environment and the exacerbation of asthma.
Down/feather bedding/synthetic bedding. 
Background. This question was considered 
by the IOM (2000) in the context of bird­
related allergy. Down bedding, compared with 
synthetic, was believed to exacerbate asthma 
because it harbored bird mites. The possibility 
was also considered that the increased wheeze 
reported among children using synthetic 
pillows resulted from increased mite exposure 
from synthetic pillows (IOM 2000). The 
IOM concluded:
• There is inadequate or insufficient evidence 
to determine whether or not an association 
exists between down pillows and the exacer­
ba  tion of symptoms or lung function in 
asthmatics. Down pillows are believed to be 
a risk factor for asthma because of their docu­
mented mite content, rather than because of 
the presence of bird allergen (IOM 2000).
Summary of new evidence. Glasgow et al. 
(2011) reported that dust mite–sensitized 
asthmatic children who used new feather 
pillows and quilts had nonsignificant reductions 
in dust mite antigen exposures and wheeze 
outcomes. Many other studies, reviewed by 
Siebers and Crane (2011), have shown that 
feather pillows or quilts, compared with 
synthetic bedding, accumulate substantially 
lower concentrations of dust mite antigen and 
are consistently protective against many respira­
tory and allergic outcomes, including asthma in 
unselected populations of infants or children; 
however, evidence was not available on exacer­
bation of existing asthma.
Conclusion.
• There is limited or suggestive evidence that 
down/feather bedding may be protective for 
various respiratory effects relative to synthetic 
bedding, presumably due to lower content of 
dust mites, although evidence is not available 
regarding exacerbation of asthma.Indoor exposures and exacerbation of asthma
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Low outdoor air ventilation rates. 
Background. Low outdoor air ventilation 
rates in buildings lead to increased indoor 
concentrations of pollutants emitted indoors 
by occupants, furnishings, equipment, 
coatings and glues, cleaning products, and 
building materials. The IOM (2000) consid­
ered evidence on whether ventilation rates 
influenced indoor exposures, and concluded 
that low ventilation rates strongly influence 
the level of many indoor exposures, including 
potential asthma triggers (IOM 2000). 
Regarding health effects, the IOM concluded:
• Existing data are inadequate for conclusions 
regarding the association between ventila­
tion rates or ventilation system microbio­
logic contamination and the exacerbation 
of asthma symptoms. However, both theo­
retical evidence and limited empirical data 
indicate that feasible modifications in venti­
lation rates can decrease or increase indoor 
concentrations of some indoor generated 
pollutants associated with asthma by ≤ 75% 
(IOM 2000).
Summary of new evidence. A substantial 
body of research, reviewed by Seppänen et al. 
(1999) suggests that lower ventilation rates 
in buildings are associated with a variety of 
symptoms, including upper and lower respi­
ratory tract symptoms. The effect may be 
mediated by transmission of respiratory infec­
tions or by increased indoor humidity, leading 
to increased dust mites, fungi, and other micro­
organisms indoors (Seppänen et al. 1999). No 
studies were identified that explicitly examine 
this relationship to exacerbation of asthma. 
The intervention study by Burr et al. (2007) 
was considered ineligible because its interven­
tion included increased outdoor air ventilation 
and mold removal, so study benefits were not 
specific to increased ventilation.
Conclusion.
• There is insufficient evidence to determine 
whether an association exists between 
lower ventilation rates in buildings and 
  exacerbations of asthma.
Discussion
This review updates previous conclusions 
(IOM 2000) with recent evidence, elevating 
the strength of evidence for some exposures 
(Table 1). Major changed conclusions include 
a documented causal relationship with exacer­
ba  tion for indoor dampness or dampness­
related agents (in children); documented 
associations with exacer  ba  tion for dampness 
or dampness­related agents (in adults), ETS 
(in preschool­age children), and endotoxin; 
and limited or suggestive evidence of associa­
tion with exacer  ba  tion for indoor culturable 
airborne Penicillium or total fungi, NO2, 
rodents (non  occupational exposure), and 
feather/down pillows (protective relative to 
synthetic bedding). There is also limited or 
suggestive evidence that dust mite, cockroach, 
dog, and dampness­related agents may exacer­
bate asthma even in nonsensitized individuals, 
suggesting proinflammatory effects.
In this review we identified limited recent 
evidence suggesting associations between 
quantified indoor culturable Penicillium or 
total fungi and exacer  ba  tion of asthma. If these 
associations are confirmed in future studies, 
this will call into question conclusions based 
on previous evidence—that available indoor 
microbial measurement strategies, especially 
culture­based assays of air samples, are not 
informative regarding indoor mold­related 
health effects (Mendell et al. 2011; World 
Health Organization 2009). Earlier reviews had 
found no consistent associations between respi­
ratory or allergic health outcomes and quanti­
tative microbial measurements. For instance, 
few studies had reported significant positive 
associations between indoor airborne cultur­
able Penicillium and specific health outcomes 
(and these did not include exacer  ba  tion of 
asthma): current asthma in adults (Dharmage 
et al. 2001); both wheeze and persistent cough 
in infants, with dose–response relationships 
(Gent et al. 2002); and respiratory infections in 
infants (Müller et al. 2002; Stark et al. 2003). 
No associations were seen between indoor 
Penicillium and allergy (Dharmage et al. 2001) 
or allergic rhinitis (Stark et al. 2005).
Specific dampness­related causal agents 
for exacer  ba  tion of asthma may include 
biologic exposures in addition to fungi, 
such as bacteria, amoebas, and dust mites, 
or nonbiologic exposures such as chemicals 
emitted from damp materials (Mendell et al. 
2011) [e.g., formaldehyde (McGwin et al. 
2010) and 2­ethyl­1­hexanol (Norbäck et al. 
2000)]. Furthermore, dampness is associated 
with respiratory infections (Fisk et al. 2010), 
the most common cause of exacer  ba  tion of 
asthma (Jackson and Johnston 2010).
Findings from interventional trials of 
single or multiple strategies, although the 
strongest study design for demonstrating 
causality, have often been inconsistent 
regarding successful reduction of exposures 
or exacer  ba  tion of asthma. A prior review has 
found that sufficient evidence is available to 
recommend three types of intervention to 
reduce asthma symptoms and possibly exacer­
ba tions:  a) tailored in­home education and 
remediation of asthma triggers, b) integrated 
pest management, and c) combined elimi­
nation of moisture intrusion or leaks and 
removal of moldy items (Krieger et al. 2010). 
Additional rigorous research is needed to 
better document causality and determine the 
effectiveness of specific remediation strategies 
(Sauni et al. 2011).
This review did not include the indoor 
intrusion of outdoor pollutants, including 
ozone, SO2, NO2, fungal spores, pollen, 
and nonbiologic PM such as diesel exhaust 
particles. Outdoor exposures to PM are associ­
ated with asthmatic symptoms (Delfino et al. 
2002; Rabinovitch et al. 2006; Sheppard 
et al. 1999) and exacerbations (Chang et al. 
2009; Salam et al. 2008; Spira­Cohen et al. 
2011). Experimental exposures to SO2 and 
ozone result in exacerbation of asthma, 
airway inflammation, and increased response 
to inhaled allergens (Linn and Gong 1999; 
Peden et al. 1995). Some strategies for 
reducing pollutant exposures indoors may also 
reduce indoor exposures to outdoor­generated 
pollutants. Such strategies might include 
using air conditioning and high­efficiency 
particulate filters in home mechanical systems, 
and thorough daily washing to remove aller­
gens settled on people (Diette et al. 2008). 
However, reducing entry of outdoor pollut­
ants by keeping doors and windows closed or 
sealing a building against air infiltration would 
result in increased indoor concentrations of 
indoor­generated pollutants, unless effectively 
enhanced particle filtration or gas air cleaning 
strategies were used. In contrast, increasing 
ventilation rate to dilute indoor­generated 
pollutants may increase indoor concentrations 
of outdoor pollutants. The advantages and 
disadvantages of ventilation­related strate­
gies for controlling indoor exposures must be 
weighed, considering the type and amounts 
of specific indoor and outdoor pollutants. For 
a more detailed discussion of the impact of 
ventilation on indoor exposures relevant to 
asthma, see Chapter 10 of the IOM review 
(IOM 2000).
This review builds on the conclusions 
of the IOM (2000) document without 
thoroughly reexamining prior evidence and 
without inclusion of unpublished studies, and 
therefore is limited in its scope and potentially 
subject to publication bias. A further limitation 
is the lack of uniformity in reviewed studies 
of the definitions for exacerbation of asthma 
and the tools for assessing exacerbation. In 
addition, the literature used in this review was 
restricted to findings published in English. 
Therefore, conclusions drawn from this review 
should be considered provisional.
In future research, the inconsistencies 
in current research may be reduced by 
improved exposure assessment, such as for 
dampness­related microbial agents (e.g., 
non–culture­based, species­specific assays) 
and determination of subjects’ sensitization. 
More rigorous study designs should be empha­
sized: performing cross­sectional studies only 
for hypothesis generation; using intervention, 
prospective, or true nested case–control designs 
to confirm associations; and conducting rigor­
ously designed intervention studies with careful 
measurements of exposures and health to 
document the causality and effectiveness of 
real­world environmental interventions.Kanchongkittiphon et al.
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Conclusions
In this review we have revised prior evidence­
based conclusions about relationships between 
specific indoor exposures and exacer  ba  tion 
of asthma. Exposures to indoor dampness 
and dampness­related agents have a causal 
relationship with exacerbation of asthma (in 
children). Exposures to dampness­related 
agents (in adults), ETS (in preschool­age 
children), and endotoxin are associated with 
exacer  ba  tion of asthma. Exposures to indoor 
culturable Penicillium and total fungi, rodents 
(non  occupational exposure), and NO2 have 
limited or suggestive evidence for an association 
with exacer  ba  tion of asthma, and limited data 
suggest that exposures to feather/down pillows 
may have a protective association relative to 
synthetic bedding. Exposures to dust mite, 
cockroach, dog, fungi, and dampness­related 
agents also have limited or suggestive evidence 
for an association with exacerbation of asthma 
even in nonsensitized individuals, suggesting 
proinflammatory effects. Prospective or inter­
vention studies are needed to confirm hypothe­
sized associations, and rigorous real­world 
environmental intervention trials are needed to 
demonstrate effective remediation and resulting 
reductions in exacerbation of asthma.
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